Patent 8075890 was granted and assigned to Genentech on December, 2011 by the United States Patent and Trademark Office.
Variant immunoglobulins, particularly humanized antibody polypeptides are provided, along with methods for their preparation and use. Consensus immunoglobulin sequences and structural models are also provided.